🔗 Share this article

While America continues making unprecedented changes to its vaccination recommendations, a particular individual has emerged unexpectedly: Tracy Beth Høeg, a Danish American sports physician and epidemiologist who rose to prominence by casting doubt on Covid vaccinations throughout the global health crisis and has zeroed in on possible deaths following Covid vaccination in her recent tenure at the FDA.

Planned Shifts to Childhood Immunization Schedule

Agency leaders had intended to announce major revisions to the pediatric vaccination calendar earlier this month, bringing the US with the Danish national calendar, it is understood – a substantial departure that would place the US out of step with a large portion of the world with no evidence for improved outcomes. The planned update has been postponed until the coming year.

Rather than the director of the vaccine center, Høeg is set to address the audience at the event. She was just designated interim head of the FDA’s CDER, the fifth individual to head the center this calendar year.

A Shift at the FDA

Høeg's temporary position might represent a closer partnership between the pharmaceutical and vaccine divisions as Dr. Høeg and Prasad solidify control at the agency – and it signals a greater focus upon rolling back long-standing immunizations at the FDA.

The new acting director has often pushed for ending certain childhood shot schedules in the US in order to be more in line with Denmark's approach, a country with nationalized medicine and a number of inhabitants roughly the size of the state of Wisconsin.

To date statements, she has kept her attention on immunizations – usually the responsibility of Dr. Prasad, chief of the FDA’s CBER – rather than pharmaceutical oversight.

Questions Over Expertise

The appointee has little discernible background in drug development, approval processes or management, which has been customary for former heads of the biologics center. She has worked at the FDA as a top consultant to the commissioner and the vaccine center since March.

“It seems she lacks to have the necessary background” for leading the CDER, stated Dr. Jonathan Howard. “She has not conducted a scientific study. She has no expertise in managing a sizeable institution. She lacks background in drug approvals.”

Past commissioners of CBER would “understand laws and regulations and the research of drug development”, commented a former acting FDA commissioner. “Frankly, she doesn’t have the type of experience that prior appointees who ran the center have had.”

CDER has an immense portfolio at the agency, Woodcock pointed out.

“Many people just zeroes in on the new drug program, but the off-patent medication office approves a multitude of generic drugs. There’s a biosimilars division, OTC medication office and more, and every single one must be managed,” Woodcock said. “The thing you neglect, that’s the thing that I always told people is going to come back to haunt you.”

Furthermore, a substantial administrative component to the role, which supervises in excess of 5,000 staff members. “It’s a huge administrative position, if you execute it properly,” she added.

Official Statement and Contentious Policies

In response to inquiries about Høeg’s qualifications and whether this selection indicates more teamwork among FDA leaders on vaccines, a spokesperson responded that the “concerns rely on incorrect assumptions”.

“Her experience aligns with the duties of her job,” the spokesperson stated, pointing to the months Høeg spent guiding the agency head on “medication safety and oversight research, including predictive safety algorithms and shot safety tracking”.

In her interim role, Høeg inherits the commissioner’s controversial priority voucher program, a contentious rapid drug-approval program that apparently worried her predecessors. “How are these therapies being chosen for this voucher program? Who makes the choices?” Howard asked. “There’s a lot of lack of transparency occurring at the agency right now.”

In general, he remarked, “the agency appears to be shifting towards laxer regulations of pharmaceuticals, except for vaccines.”

Established Track Record on Immunizations

Concerning vaccines, Dr. Høeg has a more documented, if concerning, history, some experts observe. She released a study using unconfirmed volunteer-provided data to determine the frequency of heart inflammation after COVID-19 immunization. She consulted for the state of Florida surgeon general Joseph Ladapo, who allegedly have altered data to indicate Covid vaccinations are pose a greater threat than they are.

Included in her “policy goals” for the current federal leadership encompassed revising regulations for new vaccines and discontinuing “non-essential” immunizations, she said post-election on a audio program. At the FDA, Høeg has reportedly proposed preventing teenage boys from obtaining Covid vaccines.

“She’s an thorough true believer who begins with her beliefs and works backwards to accommodate the data in a highly misleading, untruthful fashion,” Howard said.

Taking Control and a “Push for Payback”

Dr. Høeg joined other skeptics, {like|